标题
Two decades of new drug discovery and development for Alzheimer's disease
作者
关键词
-
出版物
RSC Advances
Volume 7, Issue 10, Pages 6046-6058
出版商
Royal Society of Chemistry (RSC)
发表日期
2017-01-18
DOI
10.1039/c6ra26737h
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG)
- (2017) Silvia A. Mandel et al. JOURNAL OF ALZHEIMERS DISEASE
- Why Do So Many Drugs for Alzheimer's Disease Fail in Development? Time for New Methods and New Practices?
- (2017) Robert E. Becker et al. JOURNAL OF ALZHEIMERS DISEASE
- Phenserine Efficacy in Alzheimer's Disease
- (2017) Bengt Winblad et al. JOURNAL OF ALZHEIMERS DISEASE
- Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1–3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu2+
- (2016) Mingyan Dong et al. ACS Chemical Neuroscience
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
- (2016) Davide Seripa et al. Expert Review of Neurotherapeutics
- Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer’s disease using UPLC/ESI-Q-TOF mass spectrometry
- (2016) Hang Chu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- De novo design of a biologically active amyloid
- (2016) Rodrigo Gallardo et al. SCIENCE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era
- (2016) Xijun Wang et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
- (2016) Davide Seripa et al. Expert Review of Neurotherapeutics
- An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A 42 aggregates linked with Alzheimers disease
- (2016) J. Habchi et al. Science Advances
- Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention
- (2016) Aihua Zhang et al. Scientific Reports
- An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine
- (2016) Xijun Wang et al. Scientific Reports
- High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350
- (2016) Qi Liu et al. Scientific Reports
- Combined Experimental and Simulation Studies Suggest a Revised Mode of Action of the Anti-Alzheimer Disease Drug NQ-Trp
- (2015) Olivia Berthoumieu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
- (2015) Heii Arai et al. Current Alzheimer Research
- Inhibition of protein aggregation and amyloid formation by small molecules
- (2015) Andrew J Doig et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Destruction of amyloid fibrils by graphene through penetration and extraction of peptides
- (2015) Zaixing Yang et al. Nanoscale
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer’s Disease: A Randomized, Placebo-Controlled Study
- (2015) Niels Andreasen et al. PLoS One
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
- (2014) Aaron H Burstein et al. BMC Neurology
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- UHPLC-MS for the analytical characterization of traditional Chinese medicines
- (2014) Xijun Wang et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study
- (2014) Thomas Leyhe et al. Alzheimers Research & Therapy
- Active immunotherapy options for Alzheimer’s disease
- (2014) Bengt Winblad et al. Alzheimers Research & Therapy
- A second-generationBacilluscell factory for rare inositol production
- (2014) Kosei Tanaka et al. Bioengineered
- TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
- (2013) Lirong Wang et al. AAPS Journal
- Understanding Amyloid Fibril Nucleation and Aβ Oligomer/Drug Interactions from Computer Simulations
- (2013) Phuong Nguyen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Untangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease
- (2013) Masha G. Savelieff et al. ACS Chemical Biology
- Atomic and Dynamic Insights into the Beneficial Effect of the 1,4-Naphthoquinon-2-yl-l-tryptophan Inhibitor on Alzheimer’s Aβ1–42 Dimer in Terms of Aggregation and Toxicity
- (2013) Tong Zhang et al. ACS Chemical Neuroscience
- Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
- (2013) Jing-ying Jia et al. ACTA PHARMACOLOGICA SINICA
- The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease
- (2013) T. Jayasena et al. AGEING RESEARCH REVIEWS
- A novel approach to rapidly prevent age-related cognitive decline
- (2013) Paul A. Adlard et al. AGING CELL
- The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease
- (2013) Mark Forman et al. Alzheimers & Dementia
- Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF
- (2013) Francois Bernier et al. Alzheimers & Dementia
- Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
- (2013) Xinglong Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
- (2013) Joel Ross et al. Current Alzheimer Research
- Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study
- (2013) Izuru Miyoshi et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide
- (2013) Maximillian Zhu et al. JOURNAL OF CHEMICAL PHYSICS
- Lifespan extension by n-butanol extract from seed of Platycladus orientalis in Caenorhabditis elegans
- (2013) Haibin Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
- (2013) H. Davtyan et al. JOURNAL OF NEUROSCIENCE
- Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42 Dimer
- (2013) Tong Zhang et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Immunotherapy against amyloid pathology in Alzheimer's disease
- (2013) Daniela Galimberti et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Semagacestat's fall: where next for AD therapies?
- (2013) NATURE MEDICINE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
- (2013) Vega García-Escudero et al. Oxidative Medicine and Cellular Longevity
- Influence of the Green Tea Leaf Extract on Neurotoxicity of Aluminium Chloride in Rats
- (2013) Ankica Jelenković et al. PHYTOTHERAPY RESEARCH
- Potentiating Therapeutic Effects by Enhancing Synergism Based on Active Constituents from Traditional Medicine
- (2013) Aihua Zhang et al. PHYTOTHERAPY RESEARCH
- Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2013) Guoyan Yang et al. PLoS One
- Abnormal iron homeostasis and neurodegeneration
- (2013) Barry B. Muhoberac et al. Frontiers in Aging Neuroscience
- ACS Chemical Neuroscience Molecule Spotlight on Begacestat (GSI-953)
- (2012) Corey R. Hopkins ACS Chemical Neuroscience
- The novel BACE inhibitor MK-8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single- and multiple-dose administration
- (2012) Mark Forman et al. Alzheimers & Dementia
- Central BACE1 inhibition by LY2886721 produces opposing effects on APP processing as reflected by cerebrospinal fluid sAPPalpha and sAPPbeta
- (2012) Brian Willis et al. Alzheimers & Dementia
- BACE inhibitor LY2886721 safety and central and peripheral PK and PD in healthy subjects (HSs)
- (2012) Ferenc Martenyi et al. Alzheimers & Dementia
- First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
- (2012) Robert Lai et al. Alzheimers & Dementia
- Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
- (2012) Orly Weinreb et al. CURRENT DRUG TARGETS
- 3-(2,4-Dimethoxybenzylidene)-anabaseine: A promising candidate drug for Alzheimer's disease?
- (2012) Philippe Zawieja et al. Geriatrics & Gerontology International
- Design of β-Amyloid Aggregation Inhibitors from a Predicted Structural Motif
- (2012) Paul A. Novick et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Structures of Aβ17–42 Trimers in Isolation and with Five Small-Molecule Drugs Using a Hierarchical Computational Procedure
- (2012) Yassmine Chebaro et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury
- (2012) Marcelo Farina et al. NEUROCHEMISTRY INTERNATIONAL
- Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
- (2012) Mark A. Greenough et al. NEUROCHEMISTRY INTERNATIONAL
- Review: Systemic inflammation and Alzheimer's disease
- (2012) C. Holmes NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
- (2011) Benjamin W Miller et al. ANNALS OF PHARMACOTHERAPY
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice
- (2011) Tetsuo Fukushima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elevation of glutathione as a therapeutic strategy in Alzheimer disease
- (2011) Chava B. Pocernich et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer’s Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation
- (2011) Doris Lambracht-Washington et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
- (2011) Nathan Herrmann et al. DRUGS
- Solanezumab for Alzheimer's disease
- (2011) Hossein Samadi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
- (2011) Rafael León et al. MEDICINAL RESEARCH REVIEWS
- Aluminium, iron and copper in human brain tissues donated to the medical research council's cognitive function and ageing study
- (2011) Emily House et al. Metallomics
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- A phase II trial of huperzine A in mild to moderate Alzheimer disease
- (2011) M. S. Rafii et al. NEUROLOGY
- EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
- (2011) Jos Prickaerts et al. NEUROPHARMACOLOGY
- Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
- (2011) Laura A. Craig et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases
- (2011) Wei Zheng et al. PHARMACOLOGY & THERAPEUTICS
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nic5-15: a novel natural gamma-secretase inhibitor that attenuates brain beta-amyloid content and improves cognition
- (2010) Giulio Pasinetti et al. Alzheimers & Dementia
- A novel multivalent Abeta peptide vaccine with preclinical evidence of a central immune response that generates antisera recognizing a wide range of Abeta peptide species
- (2010) Mary J. Savage et al. Alzheimers & Dementia
- E2012: A novel gamma-secretase modulator-pharmacology part
- (2010) Toshihide Hashimoto et al. Alzheimers & Dementia
- The worldwide societal costs of dementia: Estimates for 2009
- (2010) Anders Wimo et al. Alzheimers & Dementia
- The cholinergic system in aging and neuronal degeneration
- (2010) Reinhard Schliebs et al. BEHAVIOURAL BRAIN RESEARCH
- Amino acid sequence determinants and molecular chaperones in amyloid fibril formation
- (2010) Charlotte Nerelius et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
- (2010) Bogdan Florin Gh Popescu et al. CNS Neuroscience & Therapeutics
- Metals, oxidative stress and neurodegenerative disorders
- (2010) Klaudia Jomova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor
- (2010) Roni Scherzer-Attali et al. PLoS One
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables
- (2009) Hillel Grossman et al. Alzheimers & Dementia
- Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase
- (2009) Yiping Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
- (2009) BP Imbimbo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons
- (2009) Rodrigo A. Quintanilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
- (2009) Alfred Maelicke et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer’s disease: ADAS-cog subscale results from the Alphase study
- (2009) D. Saumier et al. Journal of Nutrition Health & Aging
- Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease
- (2009) R. L. Martone et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
- (2009) Alan H Nagahara et al. NATURE MEDICINE
- Metal Ion Physiopathology in Neurodegenerative Disorders
- (2009) Silvia Bolognin et al. NEUROMOLECULAR MEDICINE
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Oxidative Stress Signaling in Alzheimers Disease
- (2008) B. Su et al. Current Alzheimer Research
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors
- (2008) Abraham Fisher Neurodegenerative Diseases
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
- Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases
- (2008) Monika Ray et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now